1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Skin conditions
  5. Psoriasis

Ixekizumab for treating moderate to severe plaque psoriasis

Technology appraisal guidance [TA442] Published: 26 April 2017

  • Guidance
  • Tools and resources
  • Information for the public
  • History

History

A list of downloadable documents created during development.

Expected publication

  • Equality Impact Assessment (Guidance development) PDF 236 KB 26 April 2017  

Final appraisal determination

  • Final appraisal determination  
  • Final appraisal determination document PDF 444 KB 10 March 2017  
  • Committee papers PDF 1.65 MB 10 March 2017  
  • Public committee slides PDF 433 KB 10 March 2017  

Draft guidance

  • Draft guidance  
  • Appraisal consultation document PDF 158 KB 01 November 2016  
  • Committee papers PDF 20.67 MB 01 November 2016  
  • Committee papers PDF 469 KB 01 November 2016  

Draft scope documents

  • Draft scope (pre-referral) PDF 138 KB 20 May 2016  
  • Provisional matrix (pre-referral) PDF 38 KB 20 May 2016  

Invitation to participate

  • Final scope PDF 87 KB 22 June 2016  
  • Final matrix PDF 90 KB 22 June 2016  
  • NICE's response to comments on the draft scope and provisional matrix PDF 118 KB 22 June 2016  
  • Equality impact assessment (Scoping) PDF 63 KB 22 June 2016